跳至主要内容
临床试验/NCT04679272
NCT04679272已完成不适用

Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients : ProCOVRA

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,000
试验地点
1
主要终点
Hospitalization rates for COVID-19

研究概览

简要总结

COVID-19 is an infectious disease caused by SARS-CoV2 virus. The objective of our study is to analyze the progression and the severity of COVID-19 in patients with RA. Indeed, few data are available on this subject, and this would allow us to improve management of COVID-19 in these potential at-risk patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Hospitalization rates for COVID-19

时间窗: 1 day

Proportion of hospitalized patients in RA group or control group. From first COVID-19 symtpoms, or first positive SARS-COV2 PCR result, to recovery.

次要结局

  • Age(1 day)
  • Number of Participants with co-morbidities(1 day)
  • Type of clinical presentation(1 day)
  • Critical care transfer rate for COVID-19 and death due to COVID-19(1 day)
  • Pulmonary comorbidities, corticosteroids or DMARDs use(1 day)
  • Type of associated treatments(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验